809 related articles for article (PubMed ID: 9176405)
21. Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients.
Fujii S; Huang S; Fong TC; Ando D; Burrows F; Jolly DJ; Nemunaitis J; Hoon DS
Cancer Gene Ther; 2000 Sep; 7(9):1220-30. PubMed ID: 11023194
[TBL] [Abstract][Full Text] [Related]
22. Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens.
Perez RP; Zhang P; Bosserhoff AK; Buettner R; Abu-Hadid M
Hum Pathol; 2000 Nov; 31(11):1381-8. PubMed ID: 11112213
[TBL] [Abstract][Full Text] [Related]
23. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
[TBL] [Abstract][Full Text] [Related]
24. Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.
Lim E; Browning J; MacGregor D; Davis ID; Cebon JS
Melanoma Res; 2006 Aug; 16(4):347-55. PubMed ID: 16845331
[TBL] [Abstract][Full Text] [Related]
25. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro.
Eberle J; Garbe C; Wang N; Orfanos CE
Pigment Cell Res; 1995 Dec; 8(6):307-13. PubMed ID: 8789739
[TBL] [Abstract][Full Text] [Related]
26. Detection of MAGE-1 tumor antigen in brain tumor.
Kuramoto T
Kurume Med J; 1997; 44(1):43-51. PubMed ID: 9154761
[TBL] [Abstract][Full Text] [Related]
27. Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates.
Griffioen M; Borghi M; Schrier PI; Osanto S; Schadendorf D
Cancer Immunol Immunother; 2004 Aug; 53(8):715-22. PubMed ID: 14997347
[TBL] [Abstract][Full Text] [Related]
28. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.
Marincola FM; Hijazi YM; Fetsch P; Salgaller ML; Rivoltini L; Cormier J; Simonis TB; Duray PH; Herlyn M; Kawakami Y; Rosenberg SA
J Immunother Emphasis Tumor Immunol; 1996 May; 19(3):192-205. PubMed ID: 8811494
[TBL] [Abstract][Full Text] [Related]
29. Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens.
Castelli C; Tarsini P; Mazzocchi A; Rini F; Rivoltini L; Ravagnani F; Gallino F; Belli F; Parmiani G
J Immunol; 1999 Feb; 162(3):1739-48. PubMed ID: 9973437
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy.
Wagner SN; Wagner C; Schultewolter T; Goos M
Cancer Immunol Immunother; 1997 Jun; 44(4):239-47. PubMed ID: 9222283
[TBL] [Abstract][Full Text] [Related]
31. High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma.
Hofbauer GF; Burkhart A; Schüler G; Dummer R; Burg G; Nestle FO
J Immunother; 2004; 27(1):73-8. PubMed ID: 14676635
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes.
Eberle J; Weitmann S; Thieck O; Pech H; Paul M; Orfanos CE
J Invest Dermatol; 1999 Jun; 112(6):925-32. PubMed ID: 10383740
[TBL] [Abstract][Full Text] [Related]
33. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.
Davids V; Kidson SH; Hanekom GS
Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating melanoma cells by RT-PCR amplification of three different melanocyte-specific mRNAs in a mouse model.
Tsukamoto K; Hirata S; Osada A; Kitamura R; Shimada S
Pigment Cell Res; 2000 Jun; 13(3):185-9. PubMed ID: 10885678
[TBL] [Abstract][Full Text] [Related]
35. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
[TBL] [Abstract][Full Text] [Related]
36. Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1.
Luo D; Chen H; Jimbow K
Exp Cell Res; 1994 Jul; 213(1):231-41. PubMed ID: 8020595
[TBL] [Abstract][Full Text] [Related]
37. Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus.
Hashimoto Y; Ito Y; Kato T; Motokawa T; Katagiri T; Itoh M
J Cutan Pathol; 2006 Mar; 33(3):207-15. PubMed ID: 16466507
[TBL] [Abstract][Full Text] [Related]
38. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
[TBL] [Abstract][Full Text] [Related]
39. Antibody responses to melanoma/melanocyte autoantigens in melanoma patients.
Huang SK; Okamoto T; Morton DL; Hoon DS
J Invest Dermatol; 1998 Oct; 111(4):662-7. PubMed ID: 9764850
[TBL] [Abstract][Full Text] [Related]
40. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]